| Role of antifungal agents in the treatment of seborrheic dermatitis. | |
| | |
MedLine Citation:
|
PMID: 15663338 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Seborrheic dermatitis is a superficial fungal disease of the skin, occurring in areas rich in sebaceous glands. It is thought that an association exists between Malassezia yeasts and seborrheic dermatitis. This may, in part, be due to an abnormal or inflammatory immune response to these yeasts. The azoles represent the largest class of antifungals used in the treatment of this disease to date. In addition to their antifungal properties, some azoles, including bifonazole, itraconazole, and ketoconazole, have demonstrated anti-inflammatory activity, which may be beneficial in alleviating symptoms. Other topical antifungal agents, such as the allylamines (terbinafine), benzylamines (butenafine), hydroxypyridones (ciclopirox), and immunomodulators (pimecrolimus and tacrolimus), have also been effective. In addition, recent studies have revealed that tea tree oil (Melaleuca oil), honey, and cinnamic acid have antifungal activity against Malassezia species, which may be of benefit in the treatment of seborrheic dermatitis. In cases where seborrheic dermatitis is widespread, the use of an oral therapy, such as ketoconazole, itraconazole, and terbinafine, may be preferred. Essentially, antifungal therapy reduces the number of yeasts on the skin, leading to an improvement in seborrheic dermatitis. With a wide availability of preparations, including creams, shampoos, and oral formulations, antifungal agents are safe and effective in the treatment of seborrheic dermatitis. |
| | |
Authors:
|
Aditya K Gupta; Karyn Nicol; Roma Batra |
Related Documents
:
|
10677928 - Coexistence of epilepsy, myasthenia gravis and psoriasis vulgaris. 20178698 - Psoriasis: can statins play a dual role? 14510968 - Epidemiology, clinical presentation and diagnosis of onychomycosis. 15708928 - Psoriasis: epidemiology, clinical features, and quality of life. 1144258 - The investigation and treatment of hyperlipidaemia in general practice. 2962718 - Anesthesia and postanesthetic considerations. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: American journal of clinical dermatology Volume: 5 ISSN: 1175-0561 ISO Abbreviation: Am J Clin Dermatol Publication Date: 2004 |
Date Detail:
|
Created Date: 2005-01-24 Completed Date: 2005-05-12 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 100895290 Medline TA: Am J Clin Dermatol Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 417-22 Citation Subset: IM |
Affiliation:
|
Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Science Center (Sunnybrook site) and the University of Toronto, Toronto, Ontario, Canada. agupta@execulink.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Cutaneous Administration, Oral Antifungal Agents / administration & dosage*, pharmacology Dermatitis, Seborrheic / drug therapy*, microbiology Humans Malassezia / drug effects Microbial Sensitivity Tests Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antifungal Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dermatologic treatment of cutaneous graft versus host disease.
Next Document: Optimal management of facial telangiectasia.